MRK · News · 20260817N
Revenue Performance and Mix
Merck & Co., Inc. · 2026-08-17 · Importance 37 · Surprise 6 · In source text
Merck recently reported quarterly revenue of $16.61 billion, exceeding analyst estimates. The report does not provide year-over-year or sequential growth rates or a segment revenue breakdown. Analysts cited reliance on Keytruda as a future sales concentration risk because patent expiration and competition could pressure the product’s revenue.
Key facts
- Merck & Co., Inc. reported quarterly revenue of $16.61 billion, exceeding estimates. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | — | Merck & Co., Inc. reported quarterly revenue of $16.61 billion, exceeding estimates. |